Amerisource Health Services LLC is recalling 6,670 100-count bottles and 2,666 500-count bottles of BluePoint Laboratories Metoprolol Succinate Extended-Release Tablets (50 mg), a medication used to treat high blood pressure and chest pain. This recall was initiated because the tablets failed dissolution tests, meaning the medication may not be released into the body at the correct rate. No incidents or injuries have been reported to date regarding this issue.
Failed dissolution means the medication may not be absorbed by the body as intended, which could lead to ineffective treatment of blood pressure or heart conditions. This poses a moderate risk to patients who rely on consistent dosing to manage cardiovascular health.
You have 2 options:
Manufactured by Alkem Laboratories Ltd., India.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.